The Prognosis of Carcinoma of the Breast in Relation to the Type of Operation Performed, British Journal of Cancer, vol.2, issue.1, pp.7-13, 1948. ,
DOI : 10.1038/bjc.1948.2
Chirurgie d'ex??r??se totale du sein, 2011. ,
DOI : 10.1016/B978-2-294-06245-2.50003-6
Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave-roussy, Cancer, vol.26, issue.5, pp.1209-1222, 1984. ,
DOI : 10.1159/000400884
Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast, New England Journal of Medicine, vol.305, issue.1, pp.6-11, 1981. ,
DOI : 10.1056/NEJM198107023050102
Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial, European Journal of Cancer and Clinical Oncology, vol.26, issue.6, pp.668-70, 1990. ,
DOI : 10.1016/0277-5379(90)90113-8
Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast Cancer, New England Journal of Medicine, vol.320, issue.13, pp.822-830, 1989. ,
DOI : 10.1056/NEJM198903303201302
Results of the National Cancer Institute early breast cancer trial, J Natl Cancer Inst Monogr, issue.11, pp.27-32, 1992. ,
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial, J Natl Cancer Inst Monogr, issue.11, pp.15-23, 1992. ,
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, issue.11, pp.19-25, 1992. ,
Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer, New England Journal of Medicine, vol.333, issue.22, pp.1456-61, 1995. ,
DOI : 10.1056/NEJM199511303332203
Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer, New England Journal of Medicine, vol.332, issue.14, pp.907-918, 1995. ,
DOI : 10.1056/NEJM199504063321402
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial, Journal of the National Cancer Institute, vol.92, issue.14, pp.1143-50, 2000. ,
DOI : 10.1093/jnci/92.14.1143
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6, European Journal of Cancer, vol.30, issue.5, pp.645-52, 1994. ,
DOI : 10.1016/0959-8049(94)90537-1
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18., Journal of Clinical Oncology, vol.15, issue.7, pp.2483-93, 1997. ,
DOI : 10.1200/JCO.1997.15.7.2483
Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902, Journal of Clinical Oncology, vol.19, issue.22, pp.4224-4261, 2001. ,
DOI : 10.1200/JCO.2001.19.22.4224
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up, Annals of Oncology, vol.10, issue.1, pp.47-52, 1999. ,
DOI : 10.1023/A:1008337009350
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation, New England Journal of Medicine, vol.347, issue.8, pp.567-75, 2002. ,
DOI : 10.1056/NEJMoa020128
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer, New England Journal of Medicine, vol.347, issue.16, pp.1227-1259, 2002. ,
DOI : 10.1056/NEJMoa020989
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet Lond Engl. 27 août, vol.378, issue.9793, pp.771-84, 2011. ,
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, The Lancet, vol.381, issue.9869, pp.805-821, 2013. ,
DOI : 10.1016/S0140-6736(12)61963-1
American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor???Positive Breast Cancer: Status Report 2004, Journal of Clinical Oncology, vol.23, issue.3, pp.619-648, 2004. ,
DOI : 10.1200/JCO.2005.09.121
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women, Cochrane Database Syst Rev, vol.14, issue.34, p.4562, 2009. ,
DOI : 10.3310/hta10340
Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group, Cancer Treatment Reviews, vol.34, issue.1, pp.3-18, 2008. ,
DOI : 10.1016/j.ctrv.2008.03.007
Clinical trials on adjuvant chemotherapy for breast cancer, Cancer, vol.33, issue.10, pp.1957-60, 1986. ,
DOI : 10.1002/1097-0142(19860515)57:10<1957::AID-CNCR2820571012>3.0.CO;2-A
Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials, BMC Cancer, vol.20, issue.suppl 1, p.153, 2007. ,
DOI : 10.1200/JCO.20.5.1215
Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review, Disponible sur, 2014. ,
DOI : 10.1002/ijc.28234
Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence, Journal of Oncology, vol.35, issue.1, p.417673, 2012. ,
DOI : 10.2165/11595910-000000000-00000
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial, The Lancet Oncology, vol.13, issue.7, pp.734-776, 2012. ,
DOI : 10.1016/S1470-2045(12)70226-7
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence, Breast Cancer Research, vol.26, issue.1, p.121, 2015. ,
DOI : 10.1093/annonc/mdu544
URL : https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-015-0634-8?site=breast-cancer-research.biomedcentral.com
The significance of axillary node levels in the study of breast carcinoma, Cancer, vol.7, issue.4, pp.776-784, 1955. ,
DOI : 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO;2-B
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011, Journal of Clinical Oncology, vol.25, issue.24, pp.3657-63, 2007. ,
DOI : 10.1200/JCO.2006.07.4062
An approach for the treatment of penile carcinoma, Cancer, vol.15, issue.2, pp.456-66, 1977. ,
DOI : 10.1148/79.2.209
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma, Archives of Surgery, vol.127, issue.4, pp.392-401, 1960. ,
DOI : 10.1001/archsurg.1992.01420040034005
Management of the axilla in women with breast cancer, The Lancet Oncology, vol.8, issue.4, pp.331-379, 2007. ,
DOI : 10.1016/S1470-2045(07)70103-1
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer, Journal of Clinical Oncology, vol.23, issue.30, pp.7703-7723, 2005. ,
DOI : 10.1200/JCO.2005.08.001
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, The Lancet Oncology, vol.11, issue.10, pp.927-960, 2010. ,
DOI : 10.1016/S1470-2045(10)70207-2
ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node., Journal of Clinical Oncology, vol.28, issue.18_suppl, p.506, 2010. ,
DOI : 10.1200/jco.2010.28.18_suppl.cra506
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?, Breast Cancer Research and Treatment, vol.18, issue.3, pp.819-844, 2012. ,
DOI : 10.1093/annonc/mdm271
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23???01): a phase 3 randomised controlled trial, The Lancet Oncology, vol.14, issue.4, pp.297-305, 2013. ,
DOI : 10.1016/S1470-2045(13)70035-4
Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes, European Journal of Surgical Oncology (EJSO), vol.41, issue.8, pp.998-1004, 2015. ,
DOI : 10.1016/j.ejso.2015.04.003
Axillary Treatment in Conservative Management of Operable Breast Cancer: Dissection or Radiotherapy? Results of a Randomized Study With 15 Years of Follow-Up, Journal of Clinical Oncology, vol.22, issue.1, pp.97-101, 2004. ,
DOI : 10.1200/JCO.2004.12.108
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes, Cancer, vol.50, issue.7, pp.1633-1675, 2000. ,
DOI : 10.1055/s-2008-1026346
Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg, avr, vol.229, issue.4, pp.536-577, 1999. ,
DOI : 10.1097/00000658-199904000-00013
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1191740/pdf
Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer, Annals of Surgical Oncology, vol.354, issue.3, pp.248-54, 2003. ,
DOI : 10.1245/ASO.2003.05.020
Ganglion sentinelle m??tastatique d???un cancer du sein : peut-on ??viter le curage axillaire compl??mentaire ?, Journal de Chirurgie, vol.144, issue.6, pp.492-501, 2007. ,
DOI : 10.1016/S0021-7697(07)79774-0
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy, Annals of Surgical Oncology, vol.20, issue.10, pp.1140-51, 2003. ,
DOI : 10.1007/978-1-4757-3462-1
Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients. OncoTargets Ther, pp.487-93, 2015. ,
Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients, Breast Cancer Research and Treatment, vol.18, issue.9, pp.371-80, 2014. ,
DOI : 10.1245/s10434-011-1593-7
New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients, BMC Cancer, vol.91, issue.2, p.66, 2008. ,
DOI : 10.1007/s10549-004-5781-z
A New Model for Predicting Non-Sentinel Lymph Node Status in Chinese Sentinel Lymph Node Positive Breast Cancer Patients, PLoS ONE, vol.12, issue.8, p.104117, 2014. ,
DOI : 10.1371/journal.pone.0104117.t005
Predicting Patients at Low Probability of Requiring Postmastectomy Radiation Therapy, Annals of Surgical Oncology, vol.61, issue.2, pp.670-677, 2007. ,
DOI : 10.1016/j.ijrobp.2004.05.069
Nomogram for the Prediction of Having Four or More Involved Nodes for Sentinel Lymph Node???Positive Breast Cancer, Journal of Clinical Oncology, vol.26, issue.13, pp.2093-2101, 2008. ,
DOI : 10.1200/JCO.2007.11.9479
International Multicenter Tool to Predict the Risk of Nonsentinel Node Metastases in Breast Cancer, JNCI: Journal of the National Cancer Institute, vol.104, issue.24, pp.1888-96, 2012. ,
DOI : 10.1093/jnci/djs455
Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study, Journal of Clinical Oncology, vol.27, issue.17, pp.2800-2808, 2009. ,
DOI : 10.1200/JCO.2008.19.7418
URL : https://hal.archives-ouvertes.fr/hal-00378786
Mod??les pr??dictifs d???envahissement des ganglions non sentinelles en cas de m??tastases des ganglions sentinelles dans le cancer du sein, Gyn??cologie Obst??trique & Fertilit??, vol.37, issue.2, pp.160-166, 2009. ,
DOI : 10.1016/j.gyobfe.2008.09.021
Prospective Multicenter Comparison of Models to Predict Four or More Involved Axillary Lymph Nodes in Patients With Breast Cancer With One to Three Metastatic Sentinel Lymph Nodes, Journal of Clinical Oncology, vol.27, issue.34, pp.5707-5719, 2009. ,
DOI : 10.1200/JCO.2009.21.9139
URL : https://hal.archives-ouvertes.fr/hal-00428538
The meaning and use of the area under a receiver operating characteristic (ROC) curve., Radiology, vol.143, issue.1, pp.29-36, 1982. ,
DOI : 10.1148/radiology.143.1.7063747
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, vol.152, issue.9, pp.1551-1558, 1983. ,
DOI : 10.1093/ajcp/65.4.439
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis, JAMA, vol.305, issue.6, pp.569-75, 2011. ,
DOI : 10.1001/jama.2011.90
URL : http://jama.jamanetwork.com/data/journals/jama/18279/joc15004_569_575.pdf
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial, The Lancet Oncology, vol.11, issue.1, pp.55-65, 2010. ,
DOI : 10.1016/S1470-2045(09)70314-6
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1???3 positive lymph nodes in an independent validation study, Breast Cancer Research and Treatment, vol.3, issue.2, pp.295-302, 2009. ,
DOI : 10.1093/jnci/94.2.116
URL : https://hal.archives-ouvertes.fr/hal-00478252
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay, BMC Medical Genomics, vol.20, issue.5, p.54, 2015. ,
DOI : 10.1158/1078-0432.CCR-13-1845
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer, New England Journal of Medicine, vol.375, issue.8, pp.717-746, 2016. ,
DOI : 10.1056/NEJMoa1602253
URL : http://spiral.imperial.ac.uk/bitstream/10044/1/39633/7/nejmoa1602253.pdf
Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients., Journal of Ultrasound in Medicine, vol.8, issue.3, pp.115-135, 1989. ,
DOI : 10.7863/jum.1989.8.3.115
Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma, Cancer, vol.25, issue.5, pp.982-990, 2002. ,
DOI : 10.1002/cncr.10786
Role of Sonography in the Diagnosis of Axillary Lymph Node Metastases in Breast Cancer: A Systematic Review, American Journal of Roentgenology, vol.186, issue.5, pp.1342-1350, 2006. ,
DOI : 10.2214/AJR.05.0936
Pre-operative Ultrasonographic Evaluation of Axillary Lymph Nodes in Breast Cancer Patients: For Which Group Still of Additional Value and in Which Group Cause for Special Attention?, Ultrasound in Medicine & Biology, vol.41, issue.11, pp.2842-2850, 2015. ,
DOI : 10.1016/j.ultrasmedbio.2015.06.013
The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1???T2 Breast Cancer, Annals of Surgical Oncology, vol.139, issue.9, pp.2897-903, 2014. ,
DOI : 10.1007/s10549-013-2561-7